Management of Anger and Irritability in Adolescents

Primary Concerns with Hydroxyzine

The American Academy of Child and Adolescent Psychiatry identifies hydroxyzine as a less commonly used agent for acute agitation, with limited controlled trial data and primarily sedative effects 1
Hydroxyzine lacks evidence for treating anger or irritability in adolescents, and guidelines only support its use for acute agitation in emergency settings—not for ongoing anger management 1, 2, 3

Drug interaction concerns exist with sertraline, as adding hydroxyzine to an SSRI creates potential for additive sedation and may complicate the clinical picture, making it harder to assess the true therapeutic response to sertraline 4
Paradoxical reactions can occur, as hydroxyzine and other antihistamines carry a risk of paradoxical increase in rage and agitation in children and adolescents, which is unpredictable unless previously documented 5
Behavioral interventions should be the foundation for managing anger and irritability, including functional behavioral assessment, positive reinforcement strategies, and de-escalation techniques 6
For acute agitation in emergency settings only, guidelines support short-acting benzodiazepines or atypical antipsychotics over hydroxyzine 1, 5
For chronic mood instability with anger, mood stabilizers or atypical antipsychotics have substantially more evidence than hydroxyzine 7, 6

The American Academy of Child and Adolescent Psychiatry recommends against using hydroxyzine as a substitute for adequate SSRI dosing, as the sedative effects of hydroxyzine may mask symptoms temporarily but will not address the underlying psychiatric condition driving the irritability 1
The combination of an SSRI with hydroxyzine increases sedation risk without established benefit for anger management in adolescents, according to the Journal of the National Comprehensive Cancer Network 4, 5
Monitor for treatment-emergent activation, as SSRIs can occasionally cause behavioral activation or disinhibition in adolescents, which should be distinguished from inadequate treatment response, as recommended by the Journal of the American Academy of Child and Adolescent Psychiatry 7